Medical expert of the article
New publications
Diphtheria: Symptoms, Complications, and Signs of Severity
Last updated: 29.10.2025
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Diphtheria is dangerous not only because of the local inflammation, but primarily because of the toxin, which attacks the heart, nerves, and respiratory tract. The severity of symptoms and the risk of complications largely depend on the extent of the local process and the speed of treatment. The most common severe complications are myocarditis and neuritis, as well as airway obstruction, especially in young children. The overall mortality rate, according to current data, is estimated at approximately 5-10 percent, higher in children under 5 years of age and adults over 40. [1]
The incubation period is typically 2-5 days, but can range from 1 to 10 days. The onset is often gradual: malaise, sore throat, loss of appetite, low-grade fever, then, after 2-3 days, a dense, gray or bluish-white film forms, tightly adherent to the mucous membrane and bleeding when removed. With severe intoxication, pallor, tachycardia, confusion, and, in severe cases, a "bull neck" due to soft tissue swelling appear. [2]
The clinical picture varies depending on the location of the infection. The oropharynx and tonsils are most commonly affected, while the larynx and nose are less commonly affected. Cutaneous and other non-respiratory forms exist. The cutaneous form is more common in the tropics and is less likely to cause systemic toxicity, but it is important as a potential reservoir for the pathogen. [3]
Even with partial vaccination, atypical and milder manifestations are possible, increasing the risk of diagnostic errors and late recognition. In a number of countries, health authority reports emphasize that the classic membrane does not always appear, and diphtheria can masquerade as common bacterial pharyngitis. This requires vigilance and the proper selection of samples for laboratory confirmation. [4]
How to recognize it at the start: clinical landmarks
The oropharyngeal form is characterized by gradual sore throat, low-grade fever, and the appearance of films on the tonsils and soft palate. The film is dense and fibrinous, causing bleeding when removed, and its spread correlates with the risk of toxic effects. Extensive films and pronounced swelling of the neck are markers of a severe course and possible early toxemia. [5]
In the laryngeal form, hoarseness, a barking cough, increasing inspiratory stridor, and the risk of rapid airway obstruction come to the fore. This is especially dangerous for children, where respiratory failure can develop more rapidly than in adults. [6]
The nasal form initially resembles rhinitis: mucopurulent discharge, later mixed with blood, and a localized thin film, often on the septum. Symptoms are usually milder, but confirmation is necessary, as the nasopharynx remains a source of transmission. [7]
The cutaneous form manifests as ulcers with sharp edges and a gray film or crust. It can persist and be associated with colonization by other bacteria, complicating the interpretation of smears. Systemic complications are less common than with the respiratory form, but laboratory testing for the toxigenicity of the strain is mandatory. [8]
Timeline of symptoms and complications
The first symptoms appear several days after infection, and membranes usually form by the second or third day of illness. In severe cases, deterioration can occur rapidly due to local obstruction and increasing intoxication. During this period, it is important to assess the voice, breathing, pulse, and degree of neck swelling. [9]
Myocarditis can occur early or weeks after the onset of the disease. It manifests as rhythm and conduction disturbances and signs of heart failure and is a leading cause of death. Early onset carries a poorer prognosis. [10]
Neuritis most often affects the motor nerves. Soft palate paralysis typically develops in the third week, while paresis of the ocular muscles, limbs, and diaphragm develops after the fifth week. If the diaphragm is affected, respiratory failure and aspiration pneumonia are possible. In most cases, neurological impairment is reversible over time. [11]
Infants and young children are more likely to develop life-threatening respiratory complications. Without treatment, carriage can persist for weeks, supporting transmission within families and communities. [12]
Table 1. Approximate timeline of clinical events
| Period | Probable events | Clinical significance |
|---|---|---|
| Day 2-5 from infection | Gradual prodromes, sore throat, subfebrile temperature | Early window for recognition and isolation |
| Day 2-3 of illness | Formation of films, increase in local pain | Marker of toxemia in extensive films |
| Any week | Airway obstruction in laryngeal form | Risk of asphyxia, immediate assistance required |
| Weeks 1-2 and later | Myocarditis, heart rhythm disturbances | The main cause of mortality |
| Weeks 3-6 and later | Neuritis, paralysis of the soft palate, diaphragm, limbs | Risk of aspiration, respiratory failure |
Forms of the disease and key symptoms
| Form | Dominant traits | What's alarming |
|---|---|---|
| Oropharyngeal | Sore throat, thick gray-white films, low fever | Extensive films, "bull neck", tachycardia |
| Laryngeal | Hoarseness, barking cough, stridor | Rapid worsening of respiratory failure |
| Nasal | Mucopurulent, then bloody discharge, local film | Duration of symptoms, contact with the outbreak |
| Skin | Ulcers with a film or crust, clear edges | Slow healing, multiple lesions |
| Rare localizations | Conjunctiva, external auditory canal, genitals | Diagnostic errors without cultures and toxin testing |
Assessing severity: clinical indicators
The severity of the disease is reflected by three groups of symptoms: the prevalence of the films, the severity of cervical edema, and systemic manifestations of toxemia. The larger the area of the films and the faster they spread, the higher the likelihood of early damage to the heart and nervous system. [13]
Cervical edema with a "bull neck" appearance, tender lymphadenopathy, increasing hoarseness, and stridor indicate a high risk of obstruction. This situation requires preparedness for early airway management by an experienced team. [14]
Systemic markers of severity include tachycardia, signs of heart failure, electrocardiogram conduction abnormalities, severe weakness, and confusion. Delay in seeking care, lack of vaccination, and the development of acute renal failure are associated with a worse prognosis. [15]
In children, respiratory complications are more common, sometimes with relatively mild local manifestations. This requires a lower threshold for hospitalization and observation. [16]
Table 2. Clinical and prognostic indicators of severe course
| Indicator | What does it mean? | Action |
|---|---|---|
| Extensive films, rapid spread | High toxemia | Urgent inpatient assessment |
| "Bull neck", increasing stridor | Risk of obstruction | Preparedness for early intubation |
| Tachycardia, rhythm disturbances | Possible myocarditis | Monitoring, consultation with a cardiologist |
| Weakness of the soft palate, choking | Early neuritis | Aspiration prevention, speech therapy |
| Low vaccination rate, late treatment | High risk of complications | Aggressive surveillance tactics |
Complications: heart
Myocarditis is the most common and dangerous complication. It can occur in the first week or later and presents with arrhythmias, conduction blocks, and signs of acute heart failure. Early development of myocarditis is associated with high mortality, necessitating rhythm monitoring even with moderate local symptoms. [17]
Critical forms include cardiogenic shock and severe arrhythmias requiring intensive care. Acute renal failure worsens the prognosis and is often associated with severe myocarditis. [18]
Even after stabilization, the risk of late cardiac complications should be considered. Patients should be monitored with symptoms, electrocardiograms, and echocardiography as indicated. [19]
Complications: nervous system
Neuritis most often affects the motor nerves. Typical early signs include nasalization of speech and choking due to soft palate paresis by the third week. Later, diplopia due to oculomotor nerve paresis, limb weakness, and rare cases of diaphragmatic paralysis with respiratory failure may develop. Most neurological disorders are reversible within weeks to months. [20]
Late neuritis requires multidisciplinary management involving a neurologist, rehabilitation specialist, and speech therapist. Prevention of aspiration is important, especially when associated with myocarditis and general weakness. [21]
Complications: respiratory tract and other organs
Airway obstruction develops due to membranes and edema, most often in the laryngeal form, and can develop rapidly. Key danger signs include increasing stridor, intercostal retractions, respiratory muscle fatigue, and decreased oxygen saturation. Immediate assessment with readiness to ensure airway patency is necessary. [22]
Secondary upper respiratory tract and ear infections are possible, as well as pneumonia, especially with swallowing disorders. Toxic renal damage has been reported, with the risk of acute failure in severe cases. These conditions require targeted monitoring and correction of fluid and electrolyte balance. [23]
Special groups and atypical presentations
Young children are more likely to develop respiratory complications more quickly. Even with a mild fever and sore throat, the combination of hoarseness, a barking cough, and stridor should be considered a reason to seek immediate medical attention. [24]
In partially vaccinated and fully vaccinated adults, milder and more atypical manifestations without a bright membrane are possible, increasing the risk of late diagnosis. Health authorities emphasize the need for clinicians to be vigilant, especially in cases of epidemiological links and travel. [25]
The cutaneous form can serve as a source of further transmission and is often associated with other cutaneous bacilli. Systemic effects of the toxin are less common, but the toxigenicity of the strain must be tested in the laboratory. [26]
Diagnostic Pitfalls and How to Avoid Them
The classic membrane is not always present, especially in vaccinated individuals, and mild respiratory cases may be indistinguishable from streptococcal pharyngitis. Therefore, if there are epidemiological grounds, swabs should be taken from the throat and nose, and in the cutaneous form, from the edge of the ulcer, followed by toxicity testing using reference methods. [27]
Strict red flag criteria are important for the clinic: increasing stridor, extensive membranes, "bull neck," tachycardia, and signs of heart failure, as well as any neurological symptoms. These signs require immediate hospitalization. [28]
Table 3. Red flags requiring immediate attention
| Sign | Why is it dangerous? | Act One |
|---|---|---|
| Stridor and intercostal retractions | Risk of asphyxia | Urgent airway assessment |
| Extensive or rapidly growing films | High toxemia | Immediate referral to hospital |
| "Bull neck", painful neck | Increasing inflammation and swelling | Observation in the emergency department |
| Tachycardia, arrhythmias | Possible myocarditis | Rhythm monitoring, cardiologist consultation |
| Dysarthria, nasalization, choking | Early neuritis | Aspiration prevention, positional therapy |
Who to distinguish during the initial examination
| State | What is similar | What to rely on to differentiate |
|---|---|---|
| Streptococcal tonsillopharyngitis | Sore throat, plaque | No dense fused film, higher fever, rapid response to antibacterial therapy without antitoxin |
| Infectious mononucleosis | Plaques on tonsils, lymphadenopathy | Hepatosplenomegaly, severe fatigue, positive monotests |
| Candidiasis of the oropharynx | White plaques | Easily removed without bleeding, often immunodeficiency |
| Unprotected epiglottitis | Pain and dysphagia | High fever, toxic appearance, severe pain on laryngoscopy, urgent visualization |
| Pseudomembranous pharyngitis of other etiologies | Dense raids | Absence of toxigenic corynebacterium according to laboratory tests |
Risk analysis by population
| Population | The main risk | What to do |
|---|---|---|
| Children under 5 years old | Rapid respiratory failure | Low threshold for hospitalization and monitoring |
| Adults over 40 years of age | Higher mortality rate | Early escalation of observation, rhythm control |
| Unvaccinated and partially vaccinated | Severe course and toxemia | Aggressive diagnostic and monitoring tactics |
| Patients with late presentation | Late cardiac and neurocomplications | Long-term observation for up to several months |
| Cutaneous forms with multiple foci | Transmission and mixed flora | Laboratory verification of toxicity and sanitation of foci |
What to do if you suspect diphtheria, taking into account complications
If there is any suspicion of respiratory disease, the patient should be isolated and referred to a hospital, with swabs taken and a clinical risk assessment conducted. Laboratory confirmation should not be awaited if there are signs of severe progression or red flags. Early action reduces the likelihood of irreversible toxic damage. [29]
Even after clinical improvement, monitoring for late complications is essential. Cardiac and neurological sequelae may manifest weeks later, so patient education and a schedule of follow-up visits are essential. Several guidelines emphasize the need for monitoring for up to three months after discharge in patients with severe complications. [30]
Health authorities remind us that a previous infection does not guarantee sufficient immunity. Patients with incomplete vaccination require catch-up immunization during their recovery period, and all close contacts should have their vaccination status assessed and be observed for up to ten days. These measures reduce the risk of new cases and delayed complications. [31]

